StockData

Escalon Medical Corp (ESMC) shareholders

ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$0.18+0.01 (+7.65%)

Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –

Ownership

Institutional holdings as of Jun 30, 2020, from 13F filings

Held by institutions
0.0%
0M of 7M shares
Institutional holders
0
0 new, 1 sold out
Net institutional buying
-0M
In Q2 2020
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
LPL Financial LLC586,7497.90%13G (passive)Mar 31, 2026

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202000M0.0%0 / 00 / 10M0M
Q1 202010M0.0%1 / 00 / 00M0M
Q3 201900M0.0%0 / 00 / 10M0M
Q2 201910M0.1%0 / 00 / 00M0M
Q1 201910M0.1%0 / 00 / 00M0M
Q4 201810M0.1%0 / 01 / 00M0M
Q3 201810M0.1%0 / 00 / 00M0M
Q2 201810M0.1%0 / 00 / 00M0M
Q1 201810M0.1%0 / 00 / 00M0M
Q4 201710M0.1%0 / 01 / 00M0M
Q3 201710M0.1%0 / 01 / 00M0M
Q2 201710M0.1%0 / 00 / 00M0M

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Richard J. DePiano Jr
President
Dec 17, 2012Returned to company+500$1.08$540127,706

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
25.3
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Escalon Medical's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?